東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Minimal residual disease testing = c...

Druley, Todd E.

FindBook

Google Book

Amazon

博客來

Minimal residual disease testing = current innovations and future directions /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Minimal residual disease testing/ edited by Todd E. Druley.
其他題名:	current innovations and future directions /
其他作者:	Druley, Todd E.
出版者:	Cham :Springer International Publishing : : 2019.,
面頁冊數:	viii, 197 p. :ill., digital ;24 cm.
內容註:	Introduction -- Minimal Residual Disease Testing in Acute Lymphoblastic Leukemia/Lymphoma -- Molecular Diagnostics for Minimal Residual Disease Analysis in Hematopoietic Malignancies -- Monitoring AML Response Using "Difference From Normal" Flow Cytometry -- ML-DS: A Unique Condition for Measurable Residual Disease Detection -- Advancements in Next Generation Sequencing for Detecting Minimal Residual Disease.
Contained By:	Springer eBooks
標題:	Diagnosis. -
電子資源:	https://doi.org/10.1007/978-3-319-94827-0
ISBN:	9783319948270

Minimal residual disease testing = current innovations and future directions /
Minimal residual disease testingcurrent innovations and future directions /[electronic resource] :edited by Todd E. Druley. - Cham :Springer International Publishing :2019. - viii, 197 p. :ill., digital ;24 cm.

Introduction -- Minimal Residual Disease Testing in Acute Lymphoblastic Leukemia/Lymphoma -- Molecular Diagnostics for Minimal Residual Disease Analysis in Hematopoietic Malignancies -- Monitoring AML Response Using "Difference From Normal" Flow Cytometry -- ML-DS: A Unique Condition for Measurable Residual Disease Detection -- Advancements in Next Generation Sequencing for Detecting Minimal Residual Disease.

This volume provides a concise yet comprehensive overview of minimal residual disease (MRD) testing. The text reviews the history of MRD testing, MRD testing for acute lymphoblastic leukemia/lymphoma, molecular diagnostics for MRD analysis in hematopoietic malignancies, the use of "difference from normal" flow cytometry in monitoring AML response, ML-DS for measurable residual disease detection, and advancements in next generation sequencing for detecting MRD. Written by experts in the field, Minimal Residual Disease Testing: Current Innovations and Future Directions is a valuable resource for hematologists, oncologists, pathologists, and radiologists on the variety of technologies available to detect MRD and how best to integrate these platforms into clinical practice.

ISBN: 9783319948270

Standard No.: 10.1007/978-3-319-94827-0doiSubjects--Topical Terms:

707211
Diagnosis.

LC Class. No.: RC71 / .M565 2019

Dewey Class. No.: 616.075

Minimal residual disease testing = current innovations and future directions /
LDR:02172nmm a2200325 a 4500 001 2178059
003 DE-He213
005 20190617155911.0
006 m d
007 cr nn 008maaau
008 191122s2019 gw s 0 eng d
020 $a 9783319948270 $q (electronic bk.)
020 $a 9783319948263 $q (paper)
024 7 $a 10.1007/978-3-319-94827-0 $2 doi
035 $a 978-3-319-94827-0
040 $a GP $c GP
041 0 $a eng
050 4 $a RC71 $b .M565 2019
072 7 $a MJF $2 bicssc
072 7 $a MED038000 $2 bisacsh
072 7 $a MJF $2 thema
082 0 4 $a 616.075 $2 23
090 $a RC71 $b .M665 2019
245 0 0 $a Minimal residual disease testing $h [electronic resource] : $b current innovations and future directions / $c edited by Todd E. Druley.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2019.
300 $a viii, 197 p. : $b ill., digital ; $c 24 cm.
505 0 $a Introduction -- Minimal Residual Disease Testing in Acute Lymphoblastic Leukemia/Lymphoma -- Molecular Diagnostics for Minimal Residual Disease Analysis in Hematopoietic Malignancies -- Monitoring AML Response Using "Difference From Normal" Flow Cytometry -- ML-DS: A Unique Condition for Measurable Residual Disease Detection -- Advancements in Next Generation Sequencing for Detecting Minimal Residual Disease.
520 $a This volume provides a concise yet comprehensive overview of minimal residual disease (MRD) testing. The text reviews the history of MRD testing, MRD testing for acute lymphoblastic leukemia/lymphoma, molecular diagnostics for MRD analysis in hematopoietic malignancies, the use of "difference from normal" flow cytometry in monitoring AML response, ML-DS for measurable residual disease detection, and advancements in next generation sequencing for detecting MRD. Written by experts in the field, Minimal Residual Disease Testing: Current Innovations and Future Directions is a valuable resource for hematologists, oncologists, pathologists, and radiologists on the variety of technologies available to detect MRD and how best to integrate these platforms into clinical practice.
650 0 $a Diagnosis. $3 707211
650 0 $a Molecular diagnosis. $3 600516
650 1 4 $a Hematology. $3 808260
650 2 4 $a Oncology. $3 751006
650 2 4 $a Pathology. $3 643180
700 1 $a Druley, Todd E. $3 3381863
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
856 4 0 $u https://doi.org/10.1007/978-3-319-94827-0
950 $a Medicine (Springer-11650)